INTEGRATIVE APPROACH TO NUTRITIONAL THERAPY IN NEUROLOGICAL DISEASES: EVIDENCE AND IMPLICATIONS.
Main Article Content
Keywords
Neurological Diseases; Nutritional Therapy; Side Effects.
Abstract
Background: Neurological diseases resulting from nervous system injuries can significantly affect
nutritional status and the physical and cognitive capacities necessary for maintaining a sufficient
diet. However, the role of nutritional therapy in addressing these challenges remains a focal point of
investigation.
Methods: An integrative literature review was conducted utilizing PePSIC, Medline, and LILACS
databases. The search strategy involved cross-referencing descriptors such as neuropathies,
nutritional therapy, efficacy, and side effects in Portuguese and English. The search period extended
from January to July 2022.
Results: After applying inclusion criteria, 175 relevant items were identified. While conventional
medical interventions for neurological conditions primarily rely on pharmacotherapy, emerging
evidence suggests the efficacy of food therapy in enhancing clinical outcomes and alleviating
symptoms. Notably, food therapy demonstrates promising results in managingadrenoleukodystrophy, ameliorating symptoms of Wernicke-Korsakoff syndrome, and mitigating
epileptic seizures.
Conclusion: Nutritional therapy is complementary to managing various neurological disorders.
Incorporating dietary interventions alongside conventional treatments holds the potential to improve
prognosis and symptom management, particularly in conditions such as adrenoleukodystrophy,
Wernicke-Korsakoff syndrome, and epilepsy. Hence, a holistic treatment approach encompassing
pharmacotherapy and dietary modifications is warranted for optimizing patient outcomes.
References
1. Ayyubova, G. (2024). Apoe4 is A risk factor and potential therapeutic target for Alzheimer's disease. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
2. Belov, V., Erwin-Grabner, T., Aghajani, M., Aleman, A., Amod, A. R., Basgoze, Z., . . . Ching, C. R. (2024). Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures. Scientific Reports, 14(1), 1084.
3. Bhatia, D., Paul, S., Acharjee, T., & Ramachairy, S. S. (2024). Biosensors and their widespread impact on human health. Sensors International, 5, 100257.
4. Bi, Y., & Uludag, K. (2024). Effects of Genetic Counseling on Reducing Prenatal Stress and Autism Rates in the Asia-Pacific Region Emerging Technologies for Health Literacy and Medical Practice (pp. 341-363): IGI Global.
5. Christogianni, A. (2025). The Benefits of Continuous Health Data Monitoring in Cardiovascular Diseases and Dementia Encyclopedia of Information Science and Technology, Sixth Edition (pp. 1-22): IGI Global.
6. De Marchi, F., Vignaroli, F., Mazzini, L., Comi, C., & Tondo, G. (2024). New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
7. Dias-Carvalho, A., Sá, S. I., Carvalho, F., Fernandes, E., & Costa, V. M. (2024). Inflammation is as common link to progressive neurological diseases. Archives of toxicology, 98(1), 95-119.
8. Foley, C., Kirkby, A., & Eccles, F. J. (2024). A meta-ethnographic synthesis of the experiences of stigma amongst people with functional neurological disorder. Disability and Rehabilitation, 46(1), 1-12.
9. Golpour-Hamedani, S., Pourmasoumi, M., Zarifi, S. H., Askari, G., Jamialahmadi, T., Bagherniya, M., & Sahebkar, A. (2024). Therapeutic effects of saffron and its components on neurodegenerative diseases. Heliyon. 10. Gombošová, L., Deptová, J., Jochmanová, I., Svoreňová, T., Veseliny, E., Zakuciová, M., . . . Ostrožovičová, M. (2024). Endoscopic Complications Are More Frequent in Levodopa– Carbidopa Intestinal Gel Treatment via JET-PEG in Parkinson’s Disease Patients Compared to
Nutritional PEG in Non-Parkinson’s Disease Patients. Journal of Clinical Medicine, 13(3), 703.
11. Goswami, D., Anuradha, U., Angati, A., Kumari, N., & Singh, R. K. (2024). Pharmacological and pathological relevance of S100 proteins in neurological disorders. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
12. Hernandez-Leon, A., Escamilla-Orozco, R. I., Tabal-Robles, A. R., Martínez-Vargas, D., Romero-Bautista, L., Escamilla-Soto, G., . . . González-Trujano, M. E. (2024). Antidepressantand anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice. Journal of Ethnopharmacology, 320, 117415.
13. Hirjak, D., Brandt, G. A., Peretzke, R., Fritze, S., Meyer-Lindenberg, A., Maier-Hein, K. H., & Neher, P. F. (2024). Microstructural white matter biomarkers of symptom severity and therapy outcome in catatonia: Rationale, study design and preliminary clinical data of the white study. Schizophrenia Research, 263, 160-168.
14. Holroyd, K. B., & Berkowitz, A. L. (2024). Metabolic and toxic myelopathies. CONTINUUM: Lifelong Learning in Neurology, 30(1), 199-223.
15. Jha, P., Dangi, N., & Sharma, S. (2024). Probiotics Show Promise as a Novel Natural Treatment for Neurological Disorders. Current Pharmaceutical Biotechnology.
16. Kakaei, M., Rehman, F. U., & Fazeli, F. (2024). The effect of chickpeas metabolites on human diseases and the application of their valuable nutritional compounds suitable for human consumption. Cellular, Molecular and Biomedical Reports, 4(1), 30-42.
17. Khairnar, S. J., Ahire, E. D., Jagtap, M. R., Surana, K. R., Kshirsagar, S. J., & Keservani, R. K. (2024). Nutritional Properties of Polyphenols Advances in Flavonoids for Human Health and Prevention of Diseases (pp. 1-22): Apple Academic Press.
18. Kirkbride, J. B., Anglin, D. M., Colman, I., Dykxhoorn, J., Jones, P. B., Patalay, P., . . . Wright, T. (2024). The social determinants of mental health and disorder: evidence, prevention, and recommendations. World psychiatry, 23(1), 58.
19. Krishnamoorthy, N. K., Kalyan, M., Hediyal, T. A., Anand, N., Kendaganna, P. H., Pendyala, G., . . . Sakharkar, M. K. (2024). Role of the Gut Bacteria-Derived Metabolite Phenylacetylglutamine in Health and Diseases. ACS omega.
20. Last, B. S., Mirhashem, R., & Yang, Y. (2024). From plan to practice: A qualitative study of public mental health therapists' session-planning practices. Psychological Services.
21. Marques, T. M., Ganda-Mall, J. P., Forsgård, R., Wall, R., Brummer, R. J., & de Vos, W. M. (2024). Correlating the gut microbiome to health and disease The gut-brain axis (pp. 1-36): Elsevier.
22. Martino Cinnera, A., Picerno, P., Bisirri, A., Koch, G., Morone, G., & Vannozzi, G. (2024). Upper limb assessment with inertial measurement units according to the international classification of functioning in stroke: a systematic review and correlation meta-analysis. Topics in Stroke Rehabilitation, 31(1), 66-85.
23. Mattsson-Carlgren, N., Collij, L. E., Stomrud, E., Binette, A. P., Ossenkoppele, R., Smith, R., . . . Strandberg, O. (2024). Plasma biomarker strategy for selecting patients with Alzheimer's disease for anti amyloid immunotherapies. JAMA neurology, 81(1), 69-78.
24. Mazzucca, C. B., Cappellano, G., & Chiocchetti, A. (2024). Nutrition, Immunity, and Aging: Current Scenario and Future Perspectives in Neurodegenerative Diseases. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
25. NEHIR, A., UCLER, N., & GEYIK, M. (2024). Neural tube defects. HEALTH & SCIENCE 2023-IV, 101.
26. Probst, Y., Luscombe, M., Hilfischer, M., Guan, V., & Houston, L. (2024). Exploring factors to interpret targeted nutrition messages for people with multiple sclerosis. Patient Education and Counseling, 119, 108039.
27. Reznik, E. (2024). A Review of a Ketogenic Diet In the Treatment of Autism Spectrum Disorder.
28. Roche, H. M., Macdonald, I. A., Schols, A., & Lanham-New, S. A. (2024). Nutrition and metabolism: John Wiley & Sons.
29. Romano, A., Primiano, G., Antonini, G., Ceccanti, M., Fenu, S., Forcina, F., . . . Manganelli, F. (2024). Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? European Journal of Neurology, 31(1), e16070.
30. Schläppi, K., Reber, E., Schönenberger, K. A., Stanga, Z., & Kurmann, S. (2024). The influence of patients' nutritional risk, nutritional status, and energy density in MEDPass versus conventional administration of oral dietary supplements–A secondary analysis of a randomized controlled trial. The Journal of nutrition, health and aging, 28(3), 100170.
31. Schulz, M.-A., Bzdok, D., Haufe, S., Haynes, J.-D., & Ritter, K. (2024). Performance reserves in brain-imaging-based phenotype prediction. Cell Reports, 43(1).
32. Sharma, M., Molina, C. A., Toyoda, K., Bereczki, D., Bangdiwala, S. I., Kasner, S. E., . . . Czlonkowska, A. (2024). Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomized, doubleanonymized, placebo-controlled, dose-finding trial. The Lancet Neurology, 23(1), 46-59.
33. Silakari, P., Yadav, A., Arora, A., Arora, A., Gulsheen, G., Kaur, P., & Sahu, S. K. (2024). Investigating Holistic Natural Strategies for The Management of Huntington's Disease. Paper presented at the BIO Web of Conferences.
34. Singh, S., Sangam, S. R., & Rajagopal, S. (2030). ROLE OF DIETARY AMINO ACIDS ON PARKINSON'S DISEASE. Food and Parkinson's disease, 1.
35. Spencer, C. M., Keilholtz, B. M., Palmer, M., & Vail, S. L. (2024). Mental and physical health correlates for emotional, intimate partner violence perpetration and victimization: A metaanalysis. Trauma, Violence, & Abuse, 25(1), 41-53.
36. Taoka, T., Ito, R., Nakamichi, R., Nakane, T., Kawai, H., & Naganawa, S. (2024). Interstitial fluidopathy of the central nervous system: an umbrella term for disorders with impaired neurofluid dynamics. Magnetic Resonance in Medical Sciences, 23(1), 1-13.
37. Tryfonos, C., Chrysafi, M., Vadikolias, K., Berberoglou, L., Vorvolakos, T., Dimoliani, S., . . . Giaginis, C. (2024). Nutritional interventional studies in patients with multiple sclerosis: a scoping review of the current clinical evidence. Journal of Neurology, 1-35.
38. Walaszek, M., Kachlik, Z., & Cubała, W. J. (2024). Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse prevention. Nutritional Neuroscience, 1-14.
39. Wang, X., Cheng, X., Liu, H., Mu, X., & Zheng, H. (2024). Food nutrition and toxicology targeting specific organs in the era of single-cell sequencing. Food Science and Human Wellness, 13(1), 75-89.
40. Xabibullayevich, S. S., Temirpulotovich, T. B., Sherboyevich, H. B., & Nematillayevna, S. D. (2024). Clinical-psychopathological and pathopsychological analysis of depressive disorders in late life. Amaliy va tibbiyot fanlari ilmiy jurnali, 3(1), 78-84.
41. Xiong, Y., Mahmood, A., & Chopp, M. (2024). Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestoration. Neural Regeneration Research, 19(1), 49-54.
42. Yılmaz, M., Atuk Kahraman, T., Kurtbeyoğlu, E., Konyalıgil Öztürk, N., & Gültekin, M. (2024). The evaluation of the nutritional status in Parkinson's disease: geriatric dietary risk index comparison with mini dietary assessment questionnaire. Nutritional Neuroscience, 27(1), 66-73.
43. Zamanian, M. Y., Terefe, E. M., Taheri, N., Kujawska, M., Tork, Y. J., Abdelbasset, W. K., . . . Alesaeidi, S. (2024). Neuroprotective and anti-inflammatory effects of pioglitazone on
Parkinson's disease: A comprehensive narrative review of clinical and experimental findings.
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
2. Belov, V., Erwin-Grabner, T., Aghajani, M., Aleman, A., Amod, A. R., Basgoze, Z., . . . Ching, C. R. (2024). Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures. Scientific Reports, 14(1), 1084.
3. Bhatia, D., Paul, S., Acharjee, T., & Ramachairy, S. S. (2024). Biosensors and their widespread impact on human health. Sensors International, 5, 100257.
4. Bi, Y., & Uludag, K. (2024). Effects of Genetic Counseling on Reducing Prenatal Stress and Autism Rates in the Asia-Pacific Region Emerging Technologies for Health Literacy and Medical Practice (pp. 341-363): IGI Global.
5. Christogianni, A. (2025). The Benefits of Continuous Health Data Monitoring in Cardiovascular Diseases and Dementia Encyclopedia of Information Science and Technology, Sixth Edition (pp. 1-22): IGI Global.
6. De Marchi, F., Vignaroli, F., Mazzini, L., Comi, C., & Tondo, G. (2024). New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
7. Dias-Carvalho, A., Sá, S. I., Carvalho, F., Fernandes, E., & Costa, V. M. (2024). Inflammation is as common link to progressive neurological diseases. Archives of toxicology, 98(1), 95-119.
8. Foley, C., Kirkby, A., & Eccles, F. J. (2024). A meta-ethnographic synthesis of the experiences of stigma amongst people with functional neurological disorder. Disability and Rehabilitation, 46(1), 1-12.
9. Golpour-Hamedani, S., Pourmasoumi, M., Zarifi, S. H., Askari, G., Jamialahmadi, T., Bagherniya, M., & Sahebkar, A. (2024). Therapeutic effects of saffron and its components on neurodegenerative diseases. Heliyon. 10. Gombošová, L., Deptová, J., Jochmanová, I., Svoreňová, T., Veseliny, E., Zakuciová, M., . . . Ostrožovičová, M. (2024). Endoscopic Complications Are More Frequent in Levodopa– Carbidopa Intestinal Gel Treatment via JET-PEG in Parkinson’s Disease Patients Compared to
Nutritional PEG in Non-Parkinson’s Disease Patients. Journal of Clinical Medicine, 13(3), 703.
11. Goswami, D., Anuradha, U., Angati, A., Kumari, N., & Singh, R. K. (2024). Pharmacological and pathological relevance of S100 proteins in neurological disorders. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
12. Hernandez-Leon, A., Escamilla-Orozco, R. I., Tabal-Robles, A. R., Martínez-Vargas, D., Romero-Bautista, L., Escamilla-Soto, G., . . . González-Trujano, M. E. (2024). Antidepressantand anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice. Journal of Ethnopharmacology, 320, 117415.
13. Hirjak, D., Brandt, G. A., Peretzke, R., Fritze, S., Meyer-Lindenberg, A., Maier-Hein, K. H., & Neher, P. F. (2024). Microstructural white matter biomarkers of symptom severity and therapy outcome in catatonia: Rationale, study design and preliminary clinical data of the white study. Schizophrenia Research, 263, 160-168.
14. Holroyd, K. B., & Berkowitz, A. L. (2024). Metabolic and toxic myelopathies. CONTINUUM: Lifelong Learning in Neurology, 30(1), 199-223.
15. Jha, P., Dangi, N., & Sharma, S. (2024). Probiotics Show Promise as a Novel Natural Treatment for Neurological Disorders. Current Pharmaceutical Biotechnology.
16. Kakaei, M., Rehman, F. U., & Fazeli, F. (2024). The effect of chickpeas metabolites on human diseases and the application of their valuable nutritional compounds suitable for human consumption. Cellular, Molecular and Biomedical Reports, 4(1), 30-42.
17. Khairnar, S. J., Ahire, E. D., Jagtap, M. R., Surana, K. R., Kshirsagar, S. J., & Keservani, R. K. (2024). Nutritional Properties of Polyphenols Advances in Flavonoids for Human Health and Prevention of Diseases (pp. 1-22): Apple Academic Press.
18. Kirkbride, J. B., Anglin, D. M., Colman, I., Dykxhoorn, J., Jones, P. B., Patalay, P., . . . Wright, T. (2024). The social determinants of mental health and disorder: evidence, prevention, and recommendations. World psychiatry, 23(1), 58.
19. Krishnamoorthy, N. K., Kalyan, M., Hediyal, T. A., Anand, N., Kendaganna, P. H., Pendyala, G., . . . Sakharkar, M. K. (2024). Role of the Gut Bacteria-Derived Metabolite Phenylacetylglutamine in Health and Diseases. ACS omega.
20. Last, B. S., Mirhashem, R., & Yang, Y. (2024). From plan to practice: A qualitative study of public mental health therapists' session-planning practices. Psychological Services.
21. Marques, T. M., Ganda-Mall, J. P., Forsgård, R., Wall, R., Brummer, R. J., & de Vos, W. M. (2024). Correlating the gut microbiome to health and disease The gut-brain axis (pp. 1-36): Elsevier.
22. Martino Cinnera, A., Picerno, P., Bisirri, A., Koch, G., Morone, G., & Vannozzi, G. (2024). Upper limb assessment with inertial measurement units according to the international classification of functioning in stroke: a systematic review and correlation meta-analysis. Topics in Stroke Rehabilitation, 31(1), 66-85.
23. Mattsson-Carlgren, N., Collij, L. E., Stomrud, E., Binette, A. P., Ossenkoppele, R., Smith, R., . . . Strandberg, O. (2024). Plasma biomarker strategy for selecting patients with Alzheimer's disease for anti amyloid immunotherapies. JAMA neurology, 81(1), 69-78.
24. Mazzucca, C. B., Cappellano, G., & Chiocchetti, A. (2024). Nutrition, Immunity, and Aging: Current Scenario and Future Perspectives in Neurodegenerative Diseases. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
25. NEHIR, A., UCLER, N., & GEYIK, M. (2024). Neural tube defects. HEALTH & SCIENCE 2023-IV, 101.
26. Probst, Y., Luscombe, M., Hilfischer, M., Guan, V., & Houston, L. (2024). Exploring factors to interpret targeted nutrition messages for people with multiple sclerosis. Patient Education and Counseling, 119, 108039.
27. Reznik, E. (2024). A Review of a Ketogenic Diet In the Treatment of Autism Spectrum Disorder.
28. Roche, H. M., Macdonald, I. A., Schols, A., & Lanham-New, S. A. (2024). Nutrition and metabolism: John Wiley & Sons.
29. Romano, A., Primiano, G., Antonini, G., Ceccanti, M., Fenu, S., Forcina, F., . . . Manganelli, F. (2024). Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? European Journal of Neurology, 31(1), e16070.
30. Schläppi, K., Reber, E., Schönenberger, K. A., Stanga, Z., & Kurmann, S. (2024). The influence of patients' nutritional risk, nutritional status, and energy density in MEDPass versus conventional administration of oral dietary supplements–A secondary analysis of a randomized controlled trial. The Journal of nutrition, health and aging, 28(3), 100170.
31. Schulz, M.-A., Bzdok, D., Haufe, S., Haynes, J.-D., & Ritter, K. (2024). Performance reserves in brain-imaging-based phenotype prediction. Cell Reports, 43(1).
32. Sharma, M., Molina, C. A., Toyoda, K., Bereczki, D., Bangdiwala, S. I., Kasner, S. E., . . . Czlonkowska, A. (2024). Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomized, doubleanonymized, placebo-controlled, dose-finding trial. The Lancet Neurology, 23(1), 46-59.
33. Silakari, P., Yadav, A., Arora, A., Arora, A., Gulsheen, G., Kaur, P., & Sahu, S. K. (2024). Investigating Holistic Natural Strategies for The Management of Huntington's Disease. Paper presented at the BIO Web of Conferences.
34. Singh, S., Sangam, S. R., & Rajagopal, S. (2030). ROLE OF DIETARY AMINO ACIDS ON PARKINSON'S DISEASE. Food and Parkinson's disease, 1.
35. Spencer, C. M., Keilholtz, B. M., Palmer, M., & Vail, S. L. (2024). Mental and physical health correlates for emotional, intimate partner violence perpetration and victimization: A metaanalysis. Trauma, Violence, & Abuse, 25(1), 41-53.
36. Taoka, T., Ito, R., Nakamichi, R., Nakane, T., Kawai, H., & Naganawa, S. (2024). Interstitial fluidopathy of the central nervous system: an umbrella term for disorders with impaired neurofluid dynamics. Magnetic Resonance in Medical Sciences, 23(1), 1-13.
37. Tryfonos, C., Chrysafi, M., Vadikolias, K., Berberoglou, L., Vorvolakos, T., Dimoliani, S., . . . Giaginis, C. (2024). Nutritional interventional studies in patients with multiple sclerosis: a scoping review of the current clinical evidence. Journal of Neurology, 1-35.
38. Walaszek, M., Kachlik, Z., & Cubała, W. J. (2024). Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse prevention. Nutritional Neuroscience, 1-14.
39. Wang, X., Cheng, X., Liu, H., Mu, X., & Zheng, H. (2024). Food nutrition and toxicology targeting specific organs in the era of single-cell sequencing. Food Science and Human Wellness, 13(1), 75-89.
40. Xabibullayevich, S. S., Temirpulotovich, T. B., Sherboyevich, H. B., & Nematillayevna, S. D. (2024). Clinical-psychopathological and pathopsychological analysis of depressive disorders in late life. Amaliy va tibbiyot fanlari ilmiy jurnali, 3(1), 78-84.
41. Xiong, Y., Mahmood, A., & Chopp, M. (2024). Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestoration. Neural Regeneration Research, 19(1), 49-54.
42. Yılmaz, M., Atuk Kahraman, T., Kurtbeyoğlu, E., Konyalıgil Öztürk, N., & Gültekin, M. (2024). The evaluation of the nutritional status in Parkinson's disease: geriatric dietary risk index comparison with mini dietary assessment questionnaire. Nutritional Neuroscience, 27(1), 66-73.
43. Zamanian, M. Y., Terefe, E. M., Taheri, N., Kujawska, M., Tork, Y. J., Abdelbasset, W. K., . . . Alesaeidi, S. (2024). Neuroprotective and anti-inflammatory effects of pioglitazone on
Parkinson's disease: A comprehensive narrative review of clinical and experimental findings.
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
Article Sidebar
Published
Apr 25, 2024
Article Details
How to Cite
Ahmad Frooq, Ayesha Erum Hadi, Abdur Rehman, Usman Ali, Mahnoor Arshad, Amgad Samir Abdelmageed Mohamed Elfeki, Ahmed Samir Abdelmageed Mohamed Elfiki, & Dr. Maimoona Maheen. (2024). INTEGRATIVE APPROACH TO NUTRITIONAL THERAPY IN NEUROLOGICAL DISEASES: EVIDENCE AND IMPLICATIONS. Journal of Population Therapeutics and Clinical Pharmacology, 31(4), 1525-1532. https://doi.org/10.53555/jptcp.v31i4.5910
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
Ahmad Frooq
MBBS, Faisalabad Medical University FMU/ PMC, Pakistan,
Ayesha Erum Hadi
Junior Resident, Dr. D.Y Patil Medical College, Hospital and Research Centre, Pune, India, Department of Diagnostic Radiology,
Abdur Rehman
Resident Physician, Department of Medicine, Ayub Teaching Hospital, Abbottabad, Pakistan,
Usman Ali
Resident Physician, Department of Medicine, Ayub Teaching Hospital, Abbottabad, Pakistan
Mahnoor Arshad
Department of Food and Nutrition, College of Home Economics, University of Peshawar, Pakistan
Amgad Samir Abdelmageed Mohamed Elfeki
Internal Medicine Resident in Egyptian Board 3rd Year, Department of Internal Medicine, Graduated From Cairo University, Egypt
Ahmed Samir Abdelmageed Mohamed Elfiki
Internal Medicine Specialist and Resident in Egyptian Board 3rd Year, Department of Internal Medicine, Graduated From Cairo University, Master Degree Ain Shams University, Egypt,
Dr. Maimoona Maheen
Medical Officer, Rawalpindi Medical University, Pakistan
How to Cite
Ahmad Frooq, Ayesha Erum Hadi, Abdur Rehman, Usman Ali, Mahnoor Arshad, Amgad Samir Abdelmageed Mohamed Elfeki, Ahmed Samir Abdelmageed Mohamed Elfiki, & Dr. Maimoona Maheen. (2024). INTEGRATIVE APPROACH TO NUTRITIONAL THERAPY IN NEUROLOGICAL DISEASES: EVIDENCE AND IMPLICATIONS. Journal of Population Therapeutics and Clinical Pharmacology, 31(4), 1525-1532. https://doi.org/10.53555/jptcp.v31i4.5910